Results 231 to 240 of about 14,850 (297)

High-dose flecainide for symptomatic relief in paramyotonia congenita/severe neonatal episodic laryngospasm due to SCN4A G1306E: a case report. [PDF]

J Med Case Rep
Ogueri V, Chong J, Fleming M, Simpson K, Sherwin E, Bharucha-Goebel D, Spurney C.   +6 more
europepmc   +1 more source

STAC3 gene congenital myopathy and malignant hyperthermia: a crossroads between neurology and anesthesia. [PDF]

Arq Neuropsiquiatr
Silva MS, Nakamura R, Arjona MR, Monaco TPCD, Malito ML, Sampaio TO, Oliveira SL, Magalhães JSA, Machado-Costa MC, Silva HCA.   +9 more
europepmc   +1 more source

From communication to action: using ordered network analysis to model team performance in clinical simulation. [PDF]

BMC Med Educ
Popov V, Rochlen LR.
europepmc   +1 more source

Dantrolene for Control of Refractory Shivering in Severe Traumatic Brain Injury: A Case Study. [PDF]

Am J Case Rep
Kuboyama A, Sasaki K, Tagami T, Yoshino Y, Watanabe A, Otake K, Inoue J.   +6 more
europepmc   +1 more source

Catecholaminergic polymorphic ventricular tachycardia-linked ryanodine receptor variants exhibit domain-specific calcium leak and calmodulin affinity properties. [PDF]

J Physiol
Uchinoumi H, Dong X, Stefanon I, Yang Y, Ribeiro EH, Svensson B, Wehrens XHT, Yamamoto T, Cornea RL, Rebbeck RT, Yano M, Bers DM.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts.

American Journal of Physiology. Heart and Circulatory Physiology, 2023
Ryanodine receptor 2 (RyR2) hyperactivity is observed in structural heart diseases that are a result of ischemia or heart failure. It causes abnormal calcium handling and calcium leaks that cause metabolic, electrical, and mechanical dysfunction, which ...
Sharon A. George, Jaclyn Brennan-McLean, Katy A Trampel, E. Rytkin, N. R. Faye, B. Knollmann, Igor R. Efimov   +6 more
semanticscholar   +1 more source

Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes

Heart Rhythm, 2017
Jonas Herting, Jan Gummert, Lars Maier
exaly   +2 more sources